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The Guidelines on Oral Health Care for the Pregnant 
Adolescent1 of the American Academy for Pediatric Den-
tistry (AAPD) provides a revision of the latest literature 
regarding oral pathology and current treatment strategies 
for adolescent patients.1 These guidelines contain essential 
hygiene and dietary regimens for pregnant adolescents. In-
creased incidences of oral pathologies such as caries, pe-
rimolysis, xerostomia, gingivitis, and tooth mobility are 
particularly noteworthy. They are all attributed to changes 
in hormonal levels, constant vomiting or reflux symptoms, 
and carbohydrate loading during pregnancy. 
Notably, Murphey2 also relates oral complications to 
lack of patient information regarding oral health, and oral 
care access to reach optimal oral health. Precautions that 
must be taken during the first trimester are also mentioned; 
as dental professionals must balance the probable benefits 
of dental treatment with the potential risks for the pregnant 
adolescent and the fetus. 
Undoubtedly, the AAPD’s guidelines provide a well-
structured patient care plan focused on achieving the best 
possible outcome for pregnant adolescents. However, we 
have a number of comments aimed at enhancing oral care 
for special patient populations, currently not included in 
the guidelines, such as HIV+/AIDS pregnant adolescents.
Pregnant HIV+/AIDS adolescents patients should be ma-
naged with specific treatment strategies to avoid complica-
tions and damage to the fetus. Senise et al.3 state that actual 
treatment plans focus on preventing mother-to-child trans-
mission, as well as ensuring proper precautions in regards 
to the teratogenicity of high intensity antiretroviral therapy 
(HAART). The currently preferred HAART treatment in-
cludes the use of two nucleoside reverse transcriptase inhi-
bitors plus a protease inhibitor or non-nucleoside analog re-
verse transcriptase inhibitor. The use of these drugs has led 
to a substantial decrease in the frequency of HIV transmis-
sion from mother to child. Likewise, the frequency of oral 
problems has been reduced by more than 30% with the use 
of HAART, associated to a reduction of HIV viral load and 
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recovery of the immune system.4 However, viral reappea-
rance with drug-resistant microorganisms is an emergent 
phenomenon. This phase of failing HAART is when the 
HIV load increases the transmission of drug–resistant HIV 
to vulnerable patients. In countries where no specific HIV 
treatment is available, health strategies are focused on the 
eradication of opportunistic diseases, and even this strategy 
is hard to carry out. 
Current guidelines1,3 emphasize the need for precautions 
when administering drugs to adolescent pregnant patients. 
However, we believe oral pathology treatments are not ta-
king into consideration HIV+/AIDS patients who are al-
ready undergoing HAART. If proper precautions are not 
taken while administering antiretroviral drugs, pregnant 
adolescent patients may develop oral and systemic side 
effects such as anemia, hepatotoxicity, preterm delivery, 
pre-eclampsia, lipodystrophy, mitochondrial toxicity, glu-
cose intolerance, erythema multiforme, congenital abnor-
malities, hyperpigmentation, cheilitis, ulcers, perioral pa-
resthesia, and others.4 
Moreover, oral manifestations are very important early 
indicators of an HIV infection. There are three groups of 
early oral manifestations of AIDS: the first group includes 
oral candidosis (erythematous, pseudomembranous, an-
gular cheilitis), herpes simplex virus infection, linear gin-
gival, parotid enlargement, recurrent aphthous ulcers; the 
second group involves viral infections (cytomegalovirus, 
papillomavirus, herpes zoster virus, molluscum contangio-
sum, herpes simplex virus), erythema necrotizing ulcerative 
gingivitis, hairy leukoplakia and necrotizing ulcerative pe-
riodontitis, unusual ulcers and salivary glands illness; and 
finally, the third group is characterized by osteomyelitis, 
tuberculosis-related ulcers, squamous cell carcinoma and 
Kaposi sarcoma. 
Furthermore, there are many non-pharmacological fac-
tors that have been associated with an intensification of ad-
verse events, as the coinfection with hepatitis C virus or 
fungal infections. For these reasons, permanent oral health 
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care should be incorporated as a part of the management 
of HIV+/AIDS pregnant adolescents. The identification, 
management and prevention of oral manifestations should 
be a priority for every dental professional. However, clini-
cal indicators may not appear in all pregnant adolescents, 
and we must accept that it is difficult to establish if these 
patients are HIV+. That said, it is important that this infor-
mation must be included in the infection control guidelines 
for the clinical practice. 
AAPD’s guidelines1 regarding oral pathology care for 
the pregnant adolescent population lack appropriate in-
formation aimed at pregnant HIV+/AIDS adolescent pa-
tients. Oral health is strongly connected with physical and 
emotional health, and there are important increases in oral 
health needs in HIV+/AIDS individuals, especially during 
pregnancy. The current literature available2-5 has limited in-
formation regarding the above-mentioned specific patient 
group. We suggest a deep and thorough analysis, as well as 
the development of specific guidelines to provide the targe-
ted population with proper oral health care.
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